Importation Should Be Preemptive Tool During Shortages, Group Tells FDA
The Greater New York Hospital Association, in a meeting with FDA Commissioner Margaret Hamburg, says the agency should be more proactive when considering importation of unapproved drugs to mitigate a shortage.
You may also be interested in...
The new German drug register is designed to be a first step in tackling potential drug shortages on the domestic market, but it currently lacks effective solutions.
The 11-member staff CDER devotes to drug shortages is moving to the Office of the Center Director and will report to Deputy Director for Regulatory Programs Doug Throckmorton.
West-Ward could be the first to gain approval for phenylephrine in hypotension, but the drug’s widespread use as a stand-by medication during surgery could deter FDA enforcement against unapproved versions.